ARTICLE | Company News
Drug Royalty, Dura deal
June 24, 1996 7:00 AM UTC
DRI expects its royalties from DURA to increase 60 percent as a result of DURA's acquisition of Procter & Gamble's Entex product line (see below). Excluding the transaction, DRI had expected to earn C$450,000 in royalties from DURA for the year ending Aug. 31. ...